

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein carboxylation (GO:0018214) | 7.59488375 |
| 2 | peptidyl-glutamic acid carboxylation (GO:0017187) | 7.59488375 |
| 3 | urea metabolic process (GO:0019627) | 7.50480322 |
| 4 | urea cycle (GO:0000050) | 7.38647061 |
| 5 | nitrogen cycle metabolic process (GO:0071941) | 6.87509208 |
| 6 | arginine metabolic process (GO:0006525) | 6.23732121 |
| 7 | protein kinase C signaling (GO:0070528) | 5.75467034 |
| 8 | alkaloid metabolic process (GO:0009820) | 5.41637057 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.39221309 |
| 10 | drug catabolic process (GO:0042737) | 4.90634281 |
| 11 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.87726265 |
| 12 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.80263343 |
| 13 | DNA deamination (GO:0045006) | 4.64712315 |
| 14 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 4.62151300 |
| 15 | blood coagulation, intrinsic pathway (GO:0007597) | 4.60160051 |
| 16 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 4.46338538 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.46051968 |
| 18 | transepithelial transport (GO:0070633) | 4.42674243 |
| 19 | mitotic cell cycle arrest (GO:0071850) | 4.29446446 |
| 20 | proteasome assembly (GO:0043248) | 4.15767964 |
| 21 | type B pancreatic cell proliferation (GO:0044342) | 4.14956433 |
| 22 | regulation of phospholipid biosynthetic process (GO:0071071) | 4.13637487 |
| 23 | regulation of skeletal muscle contraction (GO:0014819) | 4.06679294 |
| 24 | GDP-mannose metabolic process (GO:0019673) | 4.05053700 |
| 25 | regulation of fibrinolysis (GO:0051917) | 4.02402954 |
| 26 | oxidative demethylation (GO:0070989) | 4.01279937 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 3.92266425 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.92095968 |
| 29 | L-phenylalanine catabolic process (GO:0006559) | 3.92095968 |
| 30 | estrogen biosynthetic process (GO:0006703) | 3.88696230 |
| 31 | exogenous drug catabolic process (GO:0042738) | 3.85190466 |
| 32 | phenylpropanoid metabolic process (GO:0009698) | 3.82326154 |
| 33 | peptidyl-glutamic acid modification (GO:0018200) | 3.81580211 |
| 34 | sulfur amino acid catabolic process (GO:0000098) | 3.79550535 |
| 35 | vitamin biosynthetic process (GO:0009110) | 3.78951049 |
| 36 | negative regulation of cell aging (GO:0090344) | 3.78174801 |
| 37 | negative regulation of fibrinolysis (GO:0051918) | 3.71478562 |
| 38 | glutamate metabolic process (GO:0006536) | 3.64349480 |
| 39 | complement activation, alternative pathway (GO:0006957) | 3.63799296 |
| 40 | regulation of protein activation cascade (GO:2000257) | 3.62805042 |
| 41 | proline metabolic process (GO:0006560) | 3.58699031 |
| 42 | detection of light stimulus involved in visual perception (GO:0050908) | 3.56470578 |
| 43 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.56470578 |
| 44 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.55387245 |
| 45 | L-phenylalanine metabolic process (GO:0006558) | 3.55387245 |
| 46 | bile acid metabolic process (GO:0008206) | 3.53151155 |
| 47 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.50881337 |
| 48 | definitive hemopoiesis (GO:0060216) | 3.50630270 |
| 49 | glucose 6-phosphate metabolic process (GO:0051156) | 3.50612738 |
| 50 | regulation of synapse structural plasticity (GO:0051823) | 3.44858547 |
| 51 | phosphate ion transmembrane transport (GO:0035435) | 3.44259582 |
| 52 | cytidine metabolic process (GO:0046087) | 3.43801780 |
| 53 | cytidine catabolic process (GO:0006216) | 3.43801780 |
| 54 | cytidine deamination (GO:0009972) | 3.43801780 |
| 55 | regulation of lipoprotein particle clearance (GO:0010984) | 3.43023118 |
| 56 | endothelium development (GO:0003158) | 3.42950714 |
| 57 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.35054863 |
| 58 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.35054863 |
| 59 | regulation of complement activation (GO:0030449) | 3.32001982 |
| 60 | regulation of cellular extravasation (GO:0002691) | 3.30605956 |
| 61 | L-methionine salvage (GO:0071267) | 3.29902974 |
| 62 | L-methionine biosynthetic process (GO:0071265) | 3.29902974 |
| 63 | amino acid salvage (GO:0043102) | 3.29902974 |
| 64 | hair cell differentiation (GO:0035315) | 3.27595844 |
| 65 | heme transport (GO:0015886) | 3.26085696 |
| 66 | fibrinolysis (GO:0042730) | 3.23588821 |
| 67 | high-density lipoprotein particle remodeling (GO:0034375) | 3.22165706 |
| 68 | sterol catabolic process (GO:0016127) | 3.21299675 |
| 69 | cholesterol catabolic process (GO:0006707) | 3.21299675 |
| 70 | iron-sulfur cluster assembly (GO:0016226) | 3.13899378 |
| 71 | metallo-sulfur cluster assembly (GO:0031163) | 3.13899378 |
| 72 | nucleotide transmembrane transport (GO:1901679) | 3.13863127 |
| 73 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.13558504 |
| 74 | epoxygenase P450 pathway (GO:0019373) | 3.12319017 |
| 75 | base-excision repair, AP site formation (GO:0006285) | 3.09092966 |
| 76 | positive regulation of TOR signaling (GO:0032008) | 3.06652380 |
| 77 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.05019784 |
| 78 | purine ribonucleotide transport (GO:0015868) | 3.04788994 |
| 79 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.01633117 |
| 80 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.98756078 |
| 81 | serine family amino acid catabolic process (GO:0009071) | 2.98211595 |
| 82 | ethanol oxidation (GO:0006069) | 2.97195247 |
| 83 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.96458473 |
| 84 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.94855475 |
| 85 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.94172831 |
| 86 | phosphate ion transport (GO:0006817) | 2.93598319 |
| 87 | regulation of cholesterol metabolic process (GO:0090181) | 2.91596118 |
| 88 | blood vessel maturation (GO:0001955) | 2.91545192 |
| 89 | cellular response to ATP (GO:0071318) | 2.90184549 |
| 90 | DNA damage response, detection of DNA damage (GO:0042769) | 2.89325238 |
| 91 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.88538412 |
| 92 | regulation of cholesterol esterification (GO:0010872) | 2.86515685 |
| 93 | omega-hydroxylase P450 pathway (GO:0097267) | 2.86148744 |
| 94 | drug metabolic process (GO:0017144) | 2.85320484 |
| 95 | cysteine metabolic process (GO:0006534) | 2.84697649 |
| 96 | iron coordination entity transport (GO:1901678) | 2.84461923 |
| 97 | respiratory chain complex IV assembly (GO:0008535) | 2.84173079 |
| 98 | granulocyte differentiation (GO:0030851) | 2.84157707 |
| 99 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.83438818 |
| 100 | carbohydrate derivative transport (GO:1901264) | 2.83128847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.79200536 |
| 2 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.63956239 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.42036104 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.25359748 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.04141121 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.79045111 |
| 7 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.64598893 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.62911896 |
| 9 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.59244927 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.58886419 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.56163744 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.52038660 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36450655 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.28661364 |
| 15 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.22607552 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.21396346 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15404736 |
| 18 | E2F1_20622854_ChIP-Seq_HELA_Human | 2.12081717 |
| 19 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.06433179 |
| 20 | BCOR_27268052_Chip-Seq_Bcells_Human | 2.05333329 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.04724654 |
| 22 | PHF8_20622854_ChIP-Seq_HELA_Human | 2.00936083 |
| 23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.96900293 |
| 24 | P68_20966046_ChIP-Seq_HELA_Human | 1.93044132 |
| 25 | MAF_26560356_Chip-Seq_TH2_Human | 1.87443183 |
| 26 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.85002342 |
| 27 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.81911556 |
| 28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.80382758 |
| 29 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.79020536 |
| 30 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.78916735 |
| 31 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.77688933 |
| 32 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.76572893 |
| 33 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.74720171 |
| 34 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.67421800 |
| 35 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.63218266 |
| 36 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.62670083 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.62649044 |
| 38 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.62527379 |
| 39 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.61178233 |
| 40 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.60927313 |
| 41 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.58635427 |
| 42 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.57944955 |
| 43 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.57929513 |
| 44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.56541978 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.54741770 |
| 46 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.50551800 |
| 47 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.50421296 |
| 48 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47454428 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47228477 |
| 50 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.43827495 |
| 51 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.42537974 |
| 52 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.41435843 |
| 53 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.40919872 |
| 54 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.40119033 |
| 55 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.39891865 |
| 56 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.39574752 |
| 57 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.36724649 |
| 58 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.35179786 |
| 59 | ERA_21632823_ChIP-Seq_H3396_Human | 1.35143321 |
| 60 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.34462000 |
| 61 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.34363226 |
| 62 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.34246960 |
| 63 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 1.33254312 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.32211335 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30696188 |
| 66 | SA1_27219007_Chip-Seq_Bcells_Human | 1.30117641 |
| 67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30087842 |
| 68 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.29985188 |
| 69 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.29471119 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29360316 |
| 71 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.29316993 |
| 72 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.28143538 |
| 73 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.28056471 |
| 74 | P300_27268052_Chip-Seq_Bcells_Human | 1.27413222 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24137706 |
| 76 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.22403512 |
| 77 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22276401 |
| 78 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.22051409 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21340088 |
| 80 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.19346225 |
| 81 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19059233 |
| 82 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.18824641 |
| 83 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.17913695 |
| 84 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.17107165 |
| 85 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.15909559 |
| 86 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.15755687 |
| 87 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.15675745 |
| 88 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.15661903 |
| 89 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.14579864 |
| 90 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.14407720 |
| 91 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13384273 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 1.13154333 |
| 93 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.10790119 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10784662 |
| 95 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.10618464 |
| 96 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08427017 |
| 97 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.08324992 |
| 98 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.06777560 |
| 99 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.03184852 |
| 100 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02770199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.61933202 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 4.75274565 |
| 3 | MP0005365_abnormal_bile_salt | 4.47568769 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.20762134 |
| 5 | MP0005167_abnormal_blood-brain_barrier | 4.16776841 |
| 6 | MP0005360_urolithiasis | 3.33069426 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.21518618 |
| 8 | MP0003868_abnormal_feces_composition | 3.16426079 |
| 9 | MP0001986_abnormal_taste_sensitivity | 2.94697294 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.84231147 |
| 11 | MP0005171_absent_coat_pigmentation | 2.68841033 |
| 12 | MP0009697_abnormal_copulation | 2.67117834 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.46042665 |
| 14 | MP0005409_darkened_coat_color | 2.40614380 |
| 15 | MP0005083_abnormal_biliary_tract | 2.31949320 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.28323654 |
| 17 | MP0003195_calcinosis | 2.17924109 |
| 18 | MP0009840_abnormal_foam_cell | 2.07815416 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.06865580 |
| 20 | MP0003303_peritoneal_inflammation | 2.01063365 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.00160206 |
| 22 | MP0010368_abnormal_lymphatic_system | 1.90542654 |
| 23 | MP0003724_increased_susceptibility_to | 1.88023193 |
| 24 | MP0001764_abnormal_homeostasis | 1.85210284 |
| 25 | MP0001968_abnormal_touch/_nociception | 1.77845844 |
| 26 | MP0000751_myopathy | 1.77630763 |
| 27 | MP0003646_muscle_fatigue | 1.62248725 |
| 28 | MP0005410_abnormal_fertilization | 1.59959582 |
| 29 | MP0001661_extended_life_span | 1.56106431 |
| 30 | MP0005332_abnormal_amino_acid | 1.52353175 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.42989092 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 1.42848191 |
| 33 | MP0005084_abnormal_gallbladder_morpholo | 1.42349738 |
| 34 | MP0002735_abnormal_chemical_nociception | 1.31623742 |
| 35 | MP0005330_cardiomyopathy | 1.26990203 |
| 36 | MP0004147_increased_porphyrin_level | 1.25758858 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.23605706 |
| 38 | MP0002933_joint_inflammation | 1.18455775 |
| 39 | MP0003252_abnormal_bile_duct | 1.17779717 |
| 40 | MP0001529_abnormal_vocalization | 1.17448591 |
| 41 | MP0005253_abnormal_eye_physiology | 1.16926874 |
| 42 | MP0002736_abnormal_nociception_after | 1.13268350 |
| 43 | MP0003718_maternal_effect | 1.11872442 |
| 44 | MP0001873_stomach_inflammation | 1.10631602 |
| 45 | MP0010329_abnormal_lipoprotein_level | 1.10331318 |
| 46 | MP0002160_abnormal_reproductive_system | 1.08728299 |
| 47 | MP0003011_delayed_dark_adaptation | 1.07543342 |
| 48 | MP0009278_abnormal_bone_marrow | 1.03521235 |
| 49 | MP0006276_abnormal_autonomic_nervous | 1.01324193 |
| 50 | MP0000609_abnormal_liver_physiology | 1.00011316 |
| 51 | MP0010386_abnormal_urinary_bladder | 0.98256770 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 0.97872406 |
| 53 | MP0002909_abnormal_adrenal_gland | 0.93132233 |
| 54 | MP0009643_abnormal_urine_homeostasis | 0.91855769 |
| 55 | MP0001756_abnormal_urination | 0.91091856 |
| 56 | MP0009384_cardiac_valve_regurgitation | 0.90839576 |
| 57 | MP0001664_abnormal_digestion | 0.89972246 |
| 58 | MP0005551_abnormal_eye_electrophysiolog | 0.88858974 |
| 59 | MP0008004_abnormal_stomach_pH | 0.88487925 |
| 60 | MP0002638_abnormal_pupillary_reflex | 0.86242653 |
| 61 | MP0003567_abnormal_fetal_cardiomyocyte | 0.85795184 |
| 62 | MP0001919_abnormal_reproductive_system | 0.81272498 |
| 63 | MP0001324_abnormal_eye_pigmentation | 0.77934558 |
| 64 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77743029 |
| 65 | MP0004782_abnormal_surfactant_physiolog | 0.77444531 |
| 66 | MP0001905_abnormal_dopamine_level | 0.77364293 |
| 67 | MP0008872_abnormal_physiological_respon | 0.76170403 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 0.71975376 |
| 69 | MP0001545_abnormal_hematopoietic_system | 0.71975376 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 0.71395934 |
| 71 | MP0008775_abnormal_heart_ventricle | 0.70799698 |
| 72 | MP0000538_abnormal_urinary_bladder | 0.69661766 |
| 73 | MP0005464_abnormal_platelet_physiology | 0.69108107 |
| 74 | MP0002234_abnormal_pharynx_morphology | 0.67001398 |
| 75 | MP0003879_abnormal_hair_cell | 0.66970847 |
| 76 | MP0004142_abnormal_muscle_tone | 0.66846506 |
| 77 | MP0008873_increased_physiological_sensi | 0.66001709 |
| 78 | MP0001188_hyperpigmentation | 0.65036440 |
| 79 | MP0003136_yellow_coat_color | 0.64554259 |
| 80 | MP0006082_CNS_inflammation | 0.62701962 |
| 81 | MP0003137_abnormal_impulse_conducting | 0.62407904 |
| 82 | MP0001243_abnormal_dermal_layer | 0.58322266 |
| 83 | MP0003119_abnormal_digestive_system | 0.57578524 |
| 84 | MP0000367_abnormal_coat/_hair | 0.57316121 |
| 85 | MP0003448_altered_tumor_morphology | 0.57268094 |
| 86 | MP0000249_abnormal_blood_vessel | 0.57232395 |
| 87 | MP0002928_abnormal_bile_duct | 0.56253067 |
| 88 | MP0000467_abnormal_esophagus_morphology | 0.56024492 |
| 89 | MP0005187_abnormal_penis_morphology | 0.55628095 |
| 90 | MP0009763_increased_sensitivity_to | 0.55377213 |
| 91 | MP0001915_intracranial_hemorrhage | 0.55038177 |
| 92 | MP0001502_abnormal_circadian_rhythm | 0.54004395 |
| 93 | MP0000598_abnormal_liver_morphology | 0.53877311 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.52752151 |
| 95 | MP0005451_abnormal_body_composition | 0.51749035 |
| 96 | MP0008469_abnormal_protein_level | 0.51641986 |
| 97 | MP0003880_abnormal_central_pattern | 0.51324064 |
| 98 | MP0001663_abnormal_digestive_system | 0.51227412 |
| 99 | MP0005636_abnormal_mineral_homeostasis | 0.50884341 |
| 100 | MP0004885_abnormal_endolymph | 0.49963235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Rib fusion (HP:0000902) | 7.02966734 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 6.99101362 |
| 3 | Joint hemorrhage (HP:0005261) | 5.58019963 |
| 4 | Mesangial abnormality (HP:0001966) | 5.01483442 |
| 5 | Popliteal pterygium (HP:0009756) | 4.60688025 |
| 6 | Increased hepatocellular lipid droplets (HP:0006565) | 4.43787159 |
| 7 | Lipid accumulation in hepatocytes (HP:0006561) | 4.32200162 |
| 8 | Aplastic anemia (HP:0001915) | 4.20109595 |
| 9 | Renal Fanconi syndrome (HP:0001994) | 4.12892294 |
| 10 | Testicular atrophy (HP:0000029) | 3.98602181 |
| 11 | Akinesia (HP:0002304) | 3.95481689 |
| 12 | Fetal akinesia sequence (HP:0001989) | 3.94311651 |
| 13 | Abnormality of placental membranes (HP:0011409) | 3.90431198 |
| 14 | Amniotic constriction ring (HP:0009775) | 3.90431198 |
| 15 | Abnormality of the intrinsic pathway (HP:0010989) | 3.88423067 |
| 16 | Increased intramyocellular lipid droplets (HP:0012240) | 3.78149067 |
| 17 | Aplasia of the musculature (HP:0100854) | 3.70314906 |
| 18 | Deep venous thrombosis (HP:0002625) | 3.52566729 |
| 19 | Dyschromatopsia (HP:0007641) | 3.52397230 |
| 20 | Increased muscle lipid content (HP:0009058) | 3.48282654 |
| 21 | Attenuation of retinal blood vessels (HP:0007843) | 3.40071687 |
| 22 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.39060518 |
| 23 | Hemorrhage of the eye (HP:0011885) | 3.35814711 |
| 24 | Long clavicles (HP:0000890) | 3.28858757 |
| 25 | Facial hemangioma (HP:0000329) | 3.23297358 |
| 26 | Abnormal biliary tract physiology (HP:0012439) | 3.22205689 |
| 27 | Bile duct proliferation (HP:0001408) | 3.22205689 |
| 28 | Hypobetalipoproteinemia (HP:0003563) | 3.09396433 |
| 29 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.07618231 |
| 30 | Reduced antithrombin III activity (HP:0001976) | 3.04215792 |
| 31 | Decreased central vision (HP:0007663) | 2.94690641 |
| 32 | Respiratory distress (HP:0002098) | 2.91483741 |
| 33 | Confusion (HP:0001289) | 2.91185815 |
| 34 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.82468112 |
| 35 | Glycosuria (HP:0003076) | 2.82336988 |
| 36 | Abnormality of urine glucose concentration (HP:0011016) | 2.82336988 |
| 37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.79960072 |
| 38 | Abnormal urine phosphate concentration (HP:0012599) | 2.79207536 |
| 39 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.75588754 |
| 40 | Neonatal onset (HP:0003623) | 2.75161581 |
| 41 | Hyperphosphaturia (HP:0003109) | 2.74441862 |
| 42 | Hyperammonemia (HP:0001987) | 2.71406202 |
| 43 | Hyperglycinemia (HP:0002154) | 2.68289741 |
| 44 | Exertional dyspnea (HP:0002875) | 2.63462225 |
| 45 | Generalized aminoaciduria (HP:0002909) | 2.62513498 |
| 46 | Diminished movement (HP:0002374) | 2.61807857 |
| 47 | Abnormality of the common coagulation pathway (HP:0010990) | 2.55145248 |
| 48 | Neonatal respiratory distress (HP:0002643) | 2.51617732 |
| 49 | Vaginal fistula (HP:0004320) | 2.45852721 |
| 50 | Choroideremia (HP:0001139) | 2.44954775 |
| 51 | Chorioretinal atrophy (HP:0000533) | 2.42808559 |
| 52 | Chronic hepatic failure (HP:0100626) | 2.35961727 |
| 53 | Rectovaginal fistula (HP:0000143) | 2.35013156 |
| 54 | Rectal fistula (HP:0100590) | 2.35013156 |
| 55 | Anomalous pulmonary venous return (HP:0010772) | 2.34856728 |
| 56 | Congenital stationary night blindness (HP:0007642) | 2.33452972 |
| 57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.32571238 |
| 58 | Atrioventricular block (HP:0001678) | 2.29932173 |
| 59 | Hypophosphatemic rickets (HP:0004912) | 2.29090482 |
| 60 | Malignant hyperthermia (HP:0002047) | 2.28144295 |
| 61 | Lower limb hyperreflexia (HP:0002395) | 2.28050530 |
| 62 | Abnormality of renal resorption (HP:0011038) | 2.24041706 |
| 63 | Cholelithiasis (HP:0001081) | 2.23163637 |
| 64 | Epidermoid cyst (HP:0200040) | 2.22657835 |
| 65 | Respiratory difficulties (HP:0002880) | 2.18687964 |
| 66 | Cutaneous melanoma (HP:0012056) | 2.11720479 |
| 67 | Patellar aplasia (HP:0006443) | 2.11545546 |
| 68 | Facial diplegia (HP:0001349) | 2.09678460 |
| 69 | Annular pancreas (HP:0001734) | 2.09533001 |
| 70 | Epiphyseal stippling (HP:0010655) | 2.09271261 |
| 71 | Poikiloderma (HP:0001029) | 2.08262238 |
| 72 | Hypoplasia of the thymus (HP:0000778) | 2.08212810 |
| 73 | Flat occiput (HP:0005469) | 2.06577644 |
| 74 | Complement deficiency (HP:0004431) | 2.05542015 |
| 75 | Abnormal gallbladder morphology (HP:0012437) | 2.03900751 |
| 76 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.01980898 |
| 77 | Abnormal albumin level (HP:0012116) | 2.00941743 |
| 78 | Hypoalbuminemia (HP:0003073) | 2.00941743 |
| 79 | Fused cervical vertebrae (HP:0002949) | 1.99224199 |
| 80 | Abnormality of the pulmonary veins (HP:0011718) | 1.98857554 |
| 81 | Renal tubular dysfunction (HP:0000124) | 1.98069702 |
| 82 | Squamous cell carcinoma (HP:0002860) | 1.97691512 |
| 83 | Widely patent fontanelles and sutures (HP:0004492) | 1.96071226 |
| 84 | Spontaneous abortion (HP:0005268) | 1.93971071 |
| 85 | Turricephaly (HP:0000262) | 1.93445164 |
| 86 | Abnormality of glycine metabolism (HP:0010895) | 1.93144499 |
| 87 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.93144499 |
| 88 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.92921858 |
| 89 | Ulnar bowing (HP:0003031) | 1.92719343 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 1.91065979 |
| 91 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.90515983 |
| 92 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.90068821 |
| 93 | Hypolipoproteinemia (HP:0010981) | 1.89186097 |
| 94 | Hypoplastic heart (HP:0001961) | 1.88946879 |
| 95 | Abnormal epiphyseal ossification (HP:0010656) | 1.85614763 |
| 96 | Intestinal fistula (HP:0100819) | 1.85492174 |
| 97 | Abnormality of midbrain morphology (HP:0002418) | 1.83826839 |
| 98 | Molar tooth sign on MRI (HP:0002419) | 1.83826839 |
| 99 | Conjugated hyperbilirubinemia (HP:0002908) | 1.83227784 |
| 100 | Type I transferrin isoform profile (HP:0003642) | 1.81056185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 3.90905539 |
| 2 | BCKDK | 2.75657579 |
| 3 | GRK1 | 2.74436665 |
| 4 | TESK2 | 2.46928840 |
| 5 | EPHB1 | 2.29204465 |
| 6 | FES | 2.25958592 |
| 7 | TIE1 | 12.2348584 |
| 8 | TEC | 1.79656019 |
| 9 | CCNB1 | 1.78488989 |
| 10 | CSK | 1.51010761 |
| 11 | BMPR1B | 1.48721546 |
| 12 | KDR | 1.45445612 |
| 13 | CSNK1G3 | 1.42036930 |
| 14 | MUSK | 1.40323946 |
| 15 | MAP4K2 | 1.35340970 |
| 16 | MAP3K11 | 1.30691475 |
| 17 | SCYL2 | 1.30489616 |
| 18 | EPHA4 | 1.29295887 |
| 19 | CSNK1A1L | 1.27514518 |
| 20 | MAP2K3 | 1.25823093 |
| 21 | TGFBR2 | 1.24201362 |
| 22 | ACVR1B | 1.19695830 |
| 23 | CSNK1G1 | 1.18367150 |
| 24 | NUAK1 | 1.16498921 |
| 25 | VRK2 | 1.10738827 |
| 26 | ZAP70 | 1.10715886 |
| 27 | STK38L | 1.09846699 |
| 28 | FER | 1.03797397 |
| 29 | CDK8 | 1.00396097 |
| 30 | CSNK1G2 | 0.94677709 |
| 31 | MAP2K4 | 0.94068159 |
| 32 | TAOK3 | 0.91152601 |
| 33 | TESK1 | 0.91011861 |
| 34 | TGFBR1 | 0.90469138 |
| 35 | WNK4 | 0.84200148 |
| 36 | ADRBK2 | 0.79834805 |
| 37 | MAP2K6 | 0.79580411 |
| 38 | BLK | 0.78463717 |
| 39 | MST4 | 0.71480979 |
| 40 | CDK15 | 0.69576138 |
| 41 | CDK11A | 0.69446241 |
| 42 | CDK18 | 0.69062016 |
| 43 | BCR | 0.65644168 |
| 44 | CDK14 | 0.64698276 |
| 45 | DAPK2 | 0.61481378 |
| 46 | WNK3 | 0.59990761 |
| 47 | MATK | 0.55490165 |
| 48 | PDK2 | 0.52593432 |
| 49 | TNK2 | 0.52253322 |
| 50 | ARAF | 0.51187182 |
| 51 | BMX | 0.50759876 |
| 52 | MAPK11 | 0.50680988 |
| 53 | FGR | 0.50258576 |
| 54 | TBK1 | 0.50157433 |
| 55 | GRK6 | 0.50156537 |
| 56 | DYRK1B | 0.49897506 |
| 57 | PIM2 | 0.47847627 |
| 58 | SYK | 0.46648515 |
| 59 | CDK9 | 0.44155710 |
| 60 | AKT2 | 0.40938820 |
| 61 | MAP4K1 | 0.40280681 |
| 62 | ADRBK1 | 0.40035041 |
| 63 | PBK | 0.38783261 |
| 64 | PINK1 | 0.38671693 |
| 65 | CDK6 | 0.38315659 |
| 66 | TRIM28 | 0.36718238 |
| 67 | AURKA | 0.36232442 |
| 68 | ATR | 0.35866336 |
| 69 | PAK1 | 0.34697504 |
| 70 | BRSK1 | 0.34127073 |
| 71 | INSRR | 0.33882318 |
| 72 | MAPK12 | 0.33669947 |
| 73 | LIMK1 | 0.31079157 |
| 74 | CSNK1D | 0.29049397 |
| 75 | FLT3 | 0.26682261 |
| 76 | MAPKAPK3 | 0.26607889 |
| 77 | DAPK1 | 0.25482322 |
| 78 | EGFR | 0.24823257 |
| 79 | PRKACA | 0.24216494 |
| 80 | KIT | 0.22481902 |
| 81 | MAP3K5 | 0.22305764 |
| 82 | SRC | 0.22098144 |
| 83 | PRKCI | 0.21896524 |
| 84 | PLK2 | 0.21772448 |
| 85 | ERBB2 | 0.21125232 |
| 86 | PRKCA | 0.20688423 |
| 87 | VRK1 | 0.20308064 |
| 88 | LYN | 0.20078782 |
| 89 | MELK | 0.19209378 |
| 90 | DYRK1A | 0.18069363 |
| 91 | PRKACG | 0.17889314 |
| 92 | PRKD1 | 0.17409493 |
| 93 | DDR2 | 0.17309473 |
| 94 | HCK | 0.17157559 |
| 95 | STK10 | 0.17112998 |
| 96 | MAPK7 | 0.16823657 |
| 97 | DYRK2 | 0.16683099 |
| 98 | CLK1 | 0.16147180 |
| 99 | PIM1 | 0.15960258 |
| 100 | BUB1 | 0.14948974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 4.92217199 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.94356726 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.89905012 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.76459246 |
| 5 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.21650447 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 3.00016952 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.53629067 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.49689899 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46833281 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.31657151 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.28277651 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.27988176 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.23260125 |
| 14 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.15335187 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.14182995 |
| 16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.10220537 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.89212936 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81193089 |
| 19 | Retinol metabolism_Homo sapiens_hsa00830 | 1.77301876 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.73718034 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.56856820 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.54612226 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.53931402 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51010596 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.49382681 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.45829360 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.39572097 |
| 28 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36146198 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35723982 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.33947979 |
| 31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.31978198 |
| 32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.27481749 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.17708520 |
| 34 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.12590505 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.10731049 |
| 36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09099656 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.98205904 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97871533 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97778256 |
| 40 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97504682 |
| 41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.94634386 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.92416634 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92051559 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.92041189 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89656841 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88708801 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85418632 |
| 48 | Metabolic pathways_Homo sapiens_hsa01100 | 0.81043344 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80665917 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 0.80399085 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79607855 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79458001 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.74260572 |
| 54 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.73487634 |
| 55 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73451773 |
| 56 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73333688 |
| 57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73328460 |
| 58 | Basal transcription factors_Homo sapiens_hsa03022 | 0.71751572 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71536294 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70479606 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69180397 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65009874 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64177448 |
| 64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.62851132 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56952749 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55290012 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53130080 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50136417 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48472569 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46770191 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46517086 |
| 72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.46209759 |
| 73 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.44834242 |
| 74 | RNA polymerase_Homo sapiens_hsa03020 | 0.44278563 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44139847 |
| 76 | Proteasome_Homo sapiens_hsa03050 | 0.43985924 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.42191825 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41042866 |
| 79 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.33544970 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 0.33333312 |
| 81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.30878105 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.29546029 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28596445 |
| 84 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.27352731 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27217080 |
| 86 | Homologous recombination_Homo sapiens_hsa03440 | 0.25405080 |
| 87 | Protein export_Homo sapiens_hsa03060 | 0.23874609 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22819811 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.22040549 |
| 90 | Phototransduction_Homo sapiens_hsa04744 | 0.20775930 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.19577008 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.19146847 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18917242 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17274538 |
| 95 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.16861266 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16472318 |
| 97 | Huntingtons disease_Homo sapiens_hsa05016 | 0.15982992 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.14629378 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.13709128 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.11686206 |

